Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2020

Shelley Wood

December 31, 2020

News Opinion Editor's Corner

The Biggest News of 2020: TCTMD’s Top 10

Shelley Wood

December 28, 2020

News Daily News

As ED Visits Declined Amid COVID-19 in England, CV Deaths Ticked Up

Shelley Wood

December 23, 2020

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Features

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

Todd Neale

December 14, 2020

News Conference News AHA 2020

One in Five Patients Admitted With COVID-19 Die in the Hospital

Michael O'Riordan

November 20, 2020

News Conference News AHA 2020

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

Todd Neale

November 17, 2020

News Daily News

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Michael O'Riordan

September 30, 2020

News Daily News

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Shelley Wood

September 30, 2020

News Daily News

Influenza and Acute CV Events Can Go Hand in Hand

Caitlin E. Cox

August 25, 2020

News Daily News

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Yael L. Maxwell

August 19, 2020

News Daily News

Both CV Risk Factors, Complications Herald Higher COVID-19 Mortality

Shelley Wood

August 19, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

Shelley Wood

May 06, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2020

Shelley Wood

May 01, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Shelley Wood

March 10, 2020

News Daily News

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Yael L. Maxwell

February 18, 2020

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Todd Neale

February 10, 2020

News Daily News

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Caitlin E. Cox

February 07, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2020

The Biggest News of 2020: TCTMD’s Top 10

As ED Visits Declined Amid COVID-19 in England, CV Deaths Ticked Up

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good

One in Five Patients Admitted With COVID-19 Die in the Hospital

INVESTED: No Added CV Benefit From High-Dose Flu Vaccine

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Influenza and Acute CV Events Can Go Hand in Hand

US Mortality Rates for CVD Have Stalled as Racial Disparities Widen

Both CV Risk Factors, Complications Herald Higher COVID-19 Mortality

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

TCTMD’s Top 10 Most Popular Stories for April 2020

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Early CVD Readmissions and Mortality Patterns Differ in Canada and the US

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content